Lonza Group AG (OTCMKTS:LZAGY - Get Free Report) was the target of a large decline in short interest in March. As of March 31st, there was short interest totalling 1,600 shares, a decline of 85.0% from the March 15th total of 10,700 shares. Approximately 0.0% of the shares of the stock are sold short. Based on an average daily volume of 68,300 shares, the days-to-cover ratio is presently 0.0 days.
Lonza Group Stock Performance
Shares of Lonza Group stock traded down $0.75 during trading on Friday, reaching $65.24. 520,781 shares of the stock traded hands, compared to its average volume of 94,019. Lonza Group has a 52-week low of $52.23 and a 52-week high of $68.29. The company has a current ratio of 1.52, a quick ratio of 1.38 and a debt-to-equity ratio of 0.45. The business has a fifty day simple moving average of $63.57 and a two-hundred day simple moving average of $62.19.
Lonza Group Company Profile
(
Get Free Report)
Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments.
Recommended Stories
Before you consider Lonza Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lonza Group wasn't on the list.
While Lonza Group currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.